Glaxosmithkline Cash Balance Pension Plan — Form 5500 plan (Glaxosmithkline LLC)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Glaxosmithkline Cash Balance Pension Plan is a benefit plan reported by Glaxosmithkline LLC under EIN 23-1099050 and plan number 003. The latest loaded filing year is 2023. The filing reports 39,631 participants and $2,936,458,095 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Glaxosmithkline LLC
- EIN
- 23-1099050
- Plan number
- 003
- Plan type
- 2
- Location
- Philadelphia, PA
- Latest filing year
- 2023
- Participants
- 39,631
- End-of-year plan assets
- $2,936,458,095
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 39,631 | H, C | 20241001071846NAL0011059392001 |
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $2,936,458,095
- Total liabilities (EOY)
- $1,953,174
- Net assets (EOY)
- $2,934,504,921
- Net assets (BOY)
- $2,839,728,776
Income & contributions
- Employer contributions
- $195,000,000
- Total contributions
- $195,000,000
- Total income / additions
- $472,288,474
Expenses & distributions
- Benefits paid
- $337,454,519
- Administrative expenses
- $40,057,810
- Total expenses
- $377,512,329
- Net increase / (decrease)
- $94,776,145
Service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. | Year |
|---|---|---|---|---|
| Legal & General Invstmt Mgmt Amer | NONE | $19,107,124 | not reported in the loaded dataset | 2023 |
| Alight Solutions | RECORDKEEPER | $1,887,659 | $0 | 2023 |
| Jennison Associates LLC | NONE | $726,874 | not reported in the loaded dataset | 2023 |
| The Bank Of New York Mellon | CUSTODIAN & TRUSTEE | $529,501 | $0 | 2023 |
| Income Research & Management | NONE | $506,109 | not reported in the loaded dataset | 2023 |
| Marathon Asset Management Limited | NONE | $473,338 | not reported in the loaded dataset | 2023 |
| Walter Scott & Partners Ltd | NONE | $424,409 | not reported in the loaded dataset | 2023 |
| Genesis Asset Managers,Llp | NONE | $338,823 | not reported in the loaded dataset | 2023 |
| Towers Watson Delaware Inc | NONE | $296,845 | not reported in the loaded dataset | 2023 |
| John Hancock Life Insurance Company | NONE | $203,200 | not reported in the loaded dataset | 2023 |
| Rocaton Investment Advisors | NONE | $185,250 | not reported in the loaded dataset | 2023 |
| State Street Global Advisors | NONE | $99,762 | $0 | 2023 |
| Deloitte & Touche Llp | NONE | $85,425 | not reported in the loaded dataset | 2023 |
| Pricewaterhousecoopers Llp | NONE | $14,910 | not reported in the loaded dataset | 2023 |
Related Form 5500 pages
- All Form 5500 plans for Glaxosmithkline LLC
- 2023 Form 5500 filing
- Form 5500 filings in PA
- 401(k) and benefit plan filings in Philadelphia, PA
- Legal & General Invstmt Mgmt Amer — Schedule C compensation
- Alight Solutions — Schedule C compensation
- Jennison Associates LLC — Schedule C compensation
- The Bank Of New York Mellon — Schedule C compensation
- Income Research & Management — Schedule C compensation
- Marathon Asset Management Limited — Schedule C compensation
- Walter Scott & Partners Ltd — Schedule C compensation
- Genesis Asset Managers,Llp — Schedule C compensation
- Towers Watson Delaware Inc — Schedule C compensation
- John Hancock Life Insurance Company — Schedule C compensation
- Rocaton Investment Advisors — Schedule C compensation
- State Street Global Advisors — Schedule C compensation
- Deloitte & Touche Llp — Schedule C compensation
- Pricewaterhousecoopers Llp — Schedule C compensation